相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Disparities in Compliance With National Guidelines for the Treatment of Malignant Pleural Mesothelioma
Fernando Espinoza-Mercado et al.
ANNALS OF THORACIC SURGERY (2019)
Prognostic factors of survival in patients with malignant pleural mesothelioma: an analysis of the National Cancer Database
Maaike van Gerwen et al.
CARCINOGENESIS (2019)
National Trends in the Epidemiology of Malignant Pleural Mesothelioma: A National Cancer Data Base Study
Sahar A. Saddoughi et al.
ANNALS OF THORACIC SURGERY (2018)
Malignant Mesothelioma and Its Non-Asbestos Causes
Richard L. Attanoos et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)
Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline
Hedy L. Kindler et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Current efforts in research of pleural mesothelioma-An analysis of the ClinicalTrials.gov registry
Krisztian Suveg et al.
LUNG CANCER (2018)
The management of malignant pleural mesothelioma in the USA 2004-13-a decade of lost opportunity?
David A. Waller
JOURNAL OF THORACIC DISEASE (2018)
Novel insights and recent discoveries on the genetics and pathogenesis of malignant mesothelioma
Yin P. Hung et al.
JOURNAL OF THORACIC DISEASE (2018)
Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation
Anne S. Tsao et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Prevalence of Amyotrophic Lateral Sclerosis - United States, 2015
Paul Mehta et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
Validation of a Gene Expression Test for Mesothelioma Prognosis in Formalin-Fixed Paraffin-Embedded Tissues
Assunta De Rienzo et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients (Publication with Expression of Concern. See vol. 26, pg. 1529, 2020)
Andrea Napolitano et al.
CLINICAL CANCER RESEARCH (2016)
Mesothelin Immunotherapy for Cancer: Ready for Prime Time?
Raffit Hassan et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Consensus Report of the 2015 Weinman International Conference on Mesothelioma
Michele Carbone et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Incidence of mesothelioma in Lombardy, Italy: exposure to asbestos, time patterns and future projections
Carolina Mensi et al.
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2016)
Evaluating Early Case Capture of Pediatric Cancers in Seven Central Cancer Registries in the United States, 2013
Mary Puckett et al.
PUBLIC HEALTH REPORTS (2016)
Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-Medicare investigation of treatment patterns and overall survival
Jennifer L. Beebe-Dimmer et al.
CLINICAL EPIDEMIOLOGY (2016)
Considerations Before Establishing an Environmental Health Registry
Vinicius C. Antao et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2015)
A Federated Network for Translational Cancer Research Using Clinical Data and Biospecimens
Rebecca S. Jacobson et al.
CANCER RESEARCH (2015)
High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma
Masaki Nasu et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
The Presence of Asbestos in the Natural Environment is Likely Related to Mesothelioma in Young Individuals and Women from Southern Nevada
Francine Baumann et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
CD30 Is a Potential Therapeutic Target in Malignant Mesothelioma
Snehal Dabir et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Summary of Notifiable Noninfectious Conditions and Disease Outbreaks: Introduction to the Summary of Notifiable Noninfectious Conditions and Disease Outbreaks — United States
Ralph J. Coates et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2015)
Summary of Notifiable Noninfectious Conditions and Disease Outbreaks: Surveillance for Cancer Incidence and Mortality — United States, 2011
Simple D. Singh et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2015)
Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients
Emanuela Taioli et al.
PLOS ONE (2015)
The French mesothelioma network from 1998 to 2013
Francoise Galateau-Salle et al.
ANNALES DE PATHOLOGIE (2014)
Low PIAS3 Expression in Malignant Mesothelioma Is Associated with Increased STAT3 Activation and Poor Patient Survival
Snehal Dabir et al.
CLINICAL CANCER RESEARCH (2014)
Participation in Cancer Clinical Trials: Why Are Patients Not Participating?
Margaret M. Byrne et al.
MEDICAL DECISION MAKING (2014)
Novel 1H-Pyrrolo[2,3-b]pyridine Derivative Nortopsentin Analogues: Synthesis and Antitumor Activity in Peritoneal Mesothelioma Experimental Models
Anna Carbone et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Asbestos is not just asbestos: an unrecognised health hazard
Francine Baumann et al.
LANCET ONCOLOGY (2013)
Pleural malignant mesothelioma epidemic: Incidence, modalities of asbestos exposure and occupations involved from the Italian National Register
Alessandro Marinaccio et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Germline BAP1 mutations predispose to malignant mesothelioma
Joseph R. Testa et al.
NATURE GENETICS (2011)
Evaluation of an Attenuated Vesicular Stomatitis Virus Vector Expressing Interferon-beta for Use in Malignant Pleural Mesothelioma: Heterogeneity in Interferon Responsiveness Defines Potential Efficacy
Vassiliki Saloura et al.
HUMAN GENE THERAPY (2010)
Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma
Gretchen V. Gee et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Merkel cell polyomavirus is not detected in mesotheliomas
Kishor Bhatia et al.
JOURNAL OF CLINICAL VIROLOGY (2010)
The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer
M. Cecilia Crisanti et al.
MOLECULAR CANCER THERAPEUTICS (2009)
The development and deployment of Common Data Elements for tissue banks for translational research in cancer - An emerging standard based approach for the Mesothelioma Virtual Tissue Bank
Sambit K. Mohanty et al.
BMC CANCER (2008)
National Mesothelioma Virtual Bank: A standard based biospecimen and clinical data resource to enhance translational research
Waqas Amin et al.
BMC CANCER (2008)
The French National Mesothelioma Surveillance Program
M. Goldberg et al.
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2006)
Participation in cancer clinical trials - Race-, sex-, and age-based disparities
VH Murthy et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Malignant mesothelioma -: German mesothelioma register 1987-1999
V Neumann et al.
INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH (2001)
分享论文
